When science meets the stage: Exhibition design for pharma, biotech, and MedTech

Regulation as a design parameter

The German Advertising of Medicinal Products Act, FDA guidelines, EMA requirements: The regulatory demands on pharmaceutical communication are complex, market-specific, and non-negotiable. What is permissible in Germany may already violate compliance rules at a US congress. For exhibition design, this means: Every statement at the stand, every graphic, every interactive element must be reviewed for regulatory compliance in advance. Those who postpone this step to the end of the process risk costly rework or a stand that won't be approved. Regulation is therefore not a filter at the end, but a parameter from the start.

Develop once, deploy worldwide

Pharmaceutical companies often operate in a dozen markets simultaneously, each with different approval statuses, language requirements, and regulatory frameworks. Modular exhibition concepts are the structural answer: Core elements such as architecture, materials, and brand identity remain identical and are reused internationally. Country-specific content, claims, or product presentations can be integrated as interchangeable modules without affecting the overall concept. This not only significantly reduces production costs per trade fair, but also shortens approval processes, as only the modified elements require review.

Making science visible

Mechanisms of action, molecular structures, clinical trial results: These are topics that can hardly be presented adequately in static graphics. Interactive touchscreen applications, three-dimensional molecular models, or AR-supported visualisations make it possible to bring complex scientific concepts to life without oversimplifying them. What matters most is depth of content: The technology is only as good as the concept behind it. For medical professionals, this means study data must be presented accurately, completely, and in the right context. For decision-makers in management, the same content is needed at a different level of condensation. A well-conceived stand concept provides both.

Space for the conversations that count

At major pharmaceutical congresses such as CPHI or ESMO, exhibition stands are not merely display areas but venues for confidential professional discussions. Healthcare professionals discuss therapy options, study designs, or procurement decisions – and this requires acoustic shielding, visual discretion, and an atmosphere that enables professional communication. Consultation zones can be architecturally integrated without compromising the stand's openness and accessibility. What matters is spatial planning: Traffic flow, sightlines, and sound insulation must be considered in the floor plan from the start, not added later.

When a new product enters the market, the entire communication chain is under high pressure. Study data is released step by step, regulatory approvals come through at different times in different markets – and the trade fair season is already underway. A product launch in the pharmaceutical industry is not a one-off campaign, but a complex process that spans months and plays out across multiple formats simultaneously.

The central challenge lies in the timing mismatch. While initial congresses are already taking place, certain data cannot yet be communicated. Graphics must be approved, claims reviewed, and wording coordinated with Medical Affairs. Exhibition stands for product launches therefore need an architecture that allows for change without compromising the overall concept.

Internationally operating companies face an additional challenge. What can already be communicated in the US may not yet be approved in Europe. The spatial concept must account for these regulatory differences from the outset. Identical base structures with interchangeable content elements enable consistent brand management while ensuring local compliance.

Product launches extend far beyond the traditional exhibition stand. Roadshows, pop-up formats at specialist congresses, and temporary presentations in clinics or practices are all part of the launch ecosystem. These formats must work together seamlessly, creating a coherent brand experience that accompanies healthcare professionals from first contact through to in-depth product training.